In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp (Q36047931)

11 August 2017

In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp (English)

1 reference

Crossref

https://api.crossref.org/works/10.1128/AAC.47.10.3085-3088.2003

13 March 2024

1 reference

https://api.crossref.org/works/10.1128/AAC.47.10.3085-3088.2003

13 March 2024

author

Manuel Cuenca-Estrella

6

object named as

Manuel Cuenca-Estrella

1 reference

11 August 2017

1

Alicia Gomez-Lopez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

13 March 2024

Guillermo Garcia-Effron

2

object named as

Guillermo Garcia-Effron

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

13 March 2024

3

Emilia Mellado

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

13 March 2024

author name string

Araceli Monzon

4

1 reference

PMCID

201144

11 August 2017

Juan L. Rodriguez-Tudela

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

13 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

PMCID

201144

full work available at URL

11 August 2017

https://europepmc.org/articles/pmc201144?pdf=render

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

https://europepmc.org/articles/PMC201144

13 March 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

https://europepmc.org/articles/PMC201144?pdf=render

13 March 2024

file format

Portable Document Format

online access status

open access

content deliverer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

https://doi.org/10.1128/aac.47.10.3085-3088.2003

13 March 2024

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14506013

https://journals.asm.org/doi/pdf/10.1128/AAC.47.10.3085-3088.2003

13 March 2024

1 reference

Crossref

https://api.crossref.org/works/10.1128/AAC.47.10.3085-3088.2003

Antimicrobial Agents and Chemotherapy

13 March 2024

published in

1 reference

11 August 2017

47

1 reference

11 August 2017

10

1 reference

11 August 2017

3085-3088

1 reference

Overview: non-fumigatus species of Aspergillus: perspectives on emerging pathogens in immunocompromised hosts

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Azole cross-resistance in Aspergillus fumigatus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Uncommon opportunistic fungi: new nosocomial threats

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Optimal susceptibility testing conditions for detection of azole resistance in Aspergillus spp.: NCCLS collaborative evaluation. National Committee for Clinical Laboratory Standards

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Influence of glucose supplementation and inoculum size on growth kinetics and antifungal susceptibility testing of Candida spp

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Antifungal drug resistance in Aspergillus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Aspergillus Fumigatus antigen detection in sera from patients at risk for invasive aspergillosis.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Invasive aspergillosis caused by Aspergillus ustus: case report and review

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Aspergillus fumigatus and aspergillosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Itraconazole resistance in Aspergillus fumigatus

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Antifungal and surgical treatment of invasive aspergillosis: review of 2,121 published cases.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Comparison of the in-vitro activity of voriconazole (UK-109,496), itraconazole and amphotericin B against clinical isolates of Aspergillus fumigatus

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Invasive mold sinusitis: 17 cases in immunocompromised patients and review of the literature

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Comparative evaluation of two different methods of inoculum preparation for antifungal susceptibility testing of filamentous fungi.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=201144

Alteration of cell wall composition leads to amphotericin B resistance in Aspergillus flavus

23 September 2018

1 reference

12 December 2020

Correlation between in-vitro susceptibility testing to itraconazole and in-vivo outcome of Aspergillus fumigatus infection

1 reference

12 December 2020

Invasive aspergillosis

1 reference

12 December 2020

Invasive pulmonary aspergillosis due to Aspergillus terreus: 12-year experience and review of the literature

1 reference

12 December 2020

<i>Aspergillus fumigatus</i>and Aspergillosis

15

1 reference

Crossref

https://api.crossref.org/works/10.1128/AAC.47.10.3085-3088.2003

13 March 2024

Identifiers

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

PMCID

201144